Eptinezumab: A calcitonin gene-related peptide monoclonal antibody infusion for migraine prevention
This article seeks to analyze the clinical trials concerning the newly approved eptinezumab to assess its efficacy, safety, and application to current clinical practice. The Institute of Health US National Library of Medicine Clinical Trials, PubMed, and Cochrane Library databases were searched for...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2021-10-01
|
| Series: | SAGE Open Medicine |
| Online Access: | https://doi.org/10.1177/20503121211050186 |